Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the Nebulized Azithromycin Versus Oral Azithromycin As Anti-Inflammatory Therapy in Children With Cystic Fibrosis: A Prospective Randomized Open-Label Trial

Toktam Faghihi

Toktam Faghihi

Associate Professor of Pharmacology

Department Clinical Pharmacy

School of Pharmacy

Tehran University of Medical Sciences

Related Documents

1. Nebulized Azithromycin Versus Oral Azithromycin As Anti-Inflammatory Therapy in Children With Cystic Fibrosis: A Prospective Randomized Open-Label Trial, Iranian Journal of Pediatrics (2019)

All Documents

1. Febuxostat, a Urate-Lowering Drug Bridging From Adults to Pediatrics; a Brief Report, Clinical Therapeutics (2025)

2. A Narrative Review of Monogenic Disorders Causing Nephrolithiasis and Chronic Kidney Disease, Nephrology (2024)

3. Colistin Induced Acute Kidney Injury in Critically Ill Children: A Prospective Study Utilizing Rifle Criteria, DARU# Journal of Pharmaceutical Sciences (2022)

4. Efficacy and Safety of Low Dose Oral Ketamine for Controlling Pain and Distress During Intravenous Cannulation in Children: A Double-Blind, Randomized, Placebo-Controlled Trial, Korean Journal of Pain (2022)

5. Voriconazole Therapeutic Drug Monitoring: How to Adjust the Dose in Pediatrics?, Iranian Journal of Pediatrics (2021)

6. Nebulized Azithromycin Versus Oral Azithromycin As Anti-Inflammatory Therapy in Children With Cystic Fibrosis: A Prospective Randomized Open-Label Trial, Iranian Journal of Pediatrics (2019)

7. Impact of Preexisting Diabetes Mellitus on Transplantation Outcomes in Hematopoietic Stem Cell Transplantation, Endocrine Research (2015)

8. Transcription Errors Observed in a Teaching Hospital, Archives of Iranian Medicine (2009)